Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR

Journal of Immunological Methods

Volumn 204, Issue 1, 1997, Pages 57-66

  Favre, Nicolas ^a   Bordmann, Gérard ^a   Rudin, Werner ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

ELISA; ELISPOT; experimental murine model; interferon gamma; interleukin 4; RT PCR; tumour necrosis factor alpha

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED ICR; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030893205     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00033-1     Document Type: Article

References (30)

1. Andersson, J., Abrams, J., Bjork, L., Funa, K., Litton, M., Agren, K., Andersson, U., 1994. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology 83, 16.
2. Braga, V.M., Gendler, S.J., 1994. Co-amplification of two cDNAs in RT-PCR can alter the yield of both products. Biotechniques 17, 228.
3. Branch, D.R., Shah, A., Guilbert, L.J., 1991. A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors. J. Immunol. Methods 143, 251.
4. Burger, D., Dayer, J.M., 1995. Inhibitory cytokines and cytokine inhibitors. Neurology 45, 39.
5. Cohen, M.C., Cohen, S., 1996. Cytokine function: a study in biologic diversity. Am. J. Clin. Pathol. 105, 589.
6. Czerkinsky, C., Andersson, G., Ekre, H.P., Nilsson, L.A., Klareskog, L., Ouchterlony, O., 1988. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110, 29.
7. Czerkinsky, C., Nilsson, L.-Å., Nygren, H., Ouchterlony, Ö., Tarkowski, A., 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65, 109.
8. Debets, R., Savelkoul, H.F.J., 1994. Cytokine antagonists and their potential therapeutic use. Immunol. Today 15, 455.
9. Diaz, M.F., Kumar, A., Karimi, S., Kryworuchko, M., Daftarian, M.P., Creery, W.D., Filion, L.G., Cameron, W., 1995. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin. Exp. Immunol. 102, 31.
10. Dutcher, J.P., 1995. Therapeutic strategies for cytokines. Curr. Opin. Oncol. 7, 566.
11. Esnault, S., Benbernou, N., Lavaud, F., Shin, H.C., Potron, G., Guenounou, M., 1996. Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin. Exp. Immunol. 103, 111.
12. Espel, E., Garcia-Sanz, J.A., Aubert, V., Menoud, V., Sperisen, P., Fernández, N., Spertini, F., 1996. Transcriptional and translational control of TNF-α gene expression in human monocytes by major histocompatibility complex class II ligands. Eur. J. Immunol. 26, 1.
13. Eugster, H.-P., Müller, M., Karrer, U., Car, B.D., Schnyder, B., Eng, V.M., Woerly, G., Le Hir, M., di Padova, F., Aguet, M., Zinkernagel, R., Bluethmann, H., Ryffel, B., 1996. Multiple immune abnormalities in tumour necrosis factor and lymphotoxin a double-deficient mice. Int. Immunol. 8, 23.
14. Favre, N., Erb, P., 1993. Use of the CTL44 cell line, a derivative of CTL/L cells, to identify and quantify mouse interleukin-4 by bioassay. J. Immunol. Methods 164, 213.
15. Favre, N., Rudin, W., 1996. Salt-dependent performance variation of DNA polymerases in co-amplification PCR. Biotechniques 21, 28.
16. Friedhoff, P., Hahn, M., Wolfes, H., Pingoud, A., 1993. Quantitative polymerase chain reaction with oligodeoxynucleotide ligation assay/enzyme-linked immunosorbent assay detection. Anal. Biochem. 215, 9.
17. Grell, M., Douni, E., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., Scheurich, P., 1995. The transmembrane form of tumour necrosis factor is the prime activating ligand of the 80 kDa tumour necrosis factor receptor. Cell 83, 793.
18. Karasuyama, H., Melchers, F., 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5 using cDNA modified vectors. Eur. J. Immunol. 18, 97.
19. Kern, P., Hemmer, C.J., Gallati, H., Neifer, S., Kremsner, P., Dietrich, M., Porzsolt, F., 1992. Soluble tumour necrosis factor receptors correlate with parasitaemia and disease severity in human malaria. J. Infect. Dis. 166, 930.
20. Lopez-Cepero, M., Garcia-Sanz, J.A., Herbert, L., Riley, R., Handel, M.E., Podack, E.R., Lopez, D.M., 1994. Soluble and membrane-bound TNF-α are involved in the cytotoxic activity of B cells from tumour-bearing mice against tumour targets. J. Immunol. 152, 3333.
21. Mo, X.Y., Sarawar, S.R., Doherty, P.C., 1995. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 69, 1288.
22. Müller, M., Eugster, H.-P., Le Hir, M., Shakhov, A., Di Padova, F., Maurer, C., Quesniaux, V.F.J., Ryffel, B., 1996. Correction or transfer of the TNF-LTα deficient phenotype by bone marrow transplantation. Mol. Med. 2, 247.
23. Rugo, H.S., O'Hanley, P., Bishop, A.G., Pearce, M.K., Abrams, J.S., Howard, M., O'Garra, A., 1992. Local cytokine production in a murine model of Escherichia coli pyelonephritis. J. Clin. Invest. 89, 1032.
24. Scott, D.E., Gause, W.C., Finkelman, F.D., Steinberg, A.D., 1990. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J. Immunol. 145, 2183.
25. Tanguay, S., Killion, J.J., 1994. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res. 13, 259.
26. Taniguchi, A., Kohsaka, H., Carson, D.A., 1994. Competitive RT-PCR ELISA: a rapid, sensitive and non-radioactive method to quantitate cytokine mRNA. J. Immunol. Methods 169, 101.
27. van der Poll, T., Jansen, J., van Leen, D., von der Möhlen, M., Levi, M., ten Cate, H., Gallati, H., ten Gate, J.W., van Deventer, S.J.H., 1993. Release of soluble receptors for tumour necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis. 168, 955.
28. Wardle, E.N., 1993. Cytokines: an overview. Eur. J. Med. 2, 417.
29. Whiteside, T.L., 1994. Cytokines and cytokine measurements in a clinical laboratory. Clin. Diagn. Lab. Immunol. 1, 257.
30. Yoshimoto, T., Paul, W.E., 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179, 1285.